期刊文献+

外科重症监护室临床细菌分布及耐药性监测 被引量:1

Clinical bacteria distribution and drug resistance surveillance in surgical intensive care unit
下载PDF
导出
摘要 目的:讨论分析重症监护室中临床细菌的临床分布情况与耐药特性。方法:对临床分离的300株菌株,根据革兰阳性球菌与革兰阴性杆菌实施分类,且依照统一方案实施抗菌药物药敏试验。结果:300株菌株中,来自痰液的菌株标本为152株(50.7%),来自血液的菌株标本为56株(18.7%),来自尿液的菌株标本为52株(17.3%),来自粪便与伤口分泌物的菌株标本为40株(13.3%)。同时,对大肠埃希菌、鲍曼不动杆菌与克雷伯菌对抗生素具有的耐药率进行分析研究,其中大肠埃希菌耐药率最差的为头孢他啶(43.9%);克雷伯菌耐药率最差的为亚胺培南(54.4%);而鲍曼不动杆菌耐药率最差的为哌拉西林(47.8%)。结论:细菌耐药性呈现着持续增长的趋势,对高危人群与高危病区需加强有效监测。 Objective:To investigate and analyze the bacteria distribution and drug resistance surveillance in surgical intensive care unit(ICU).Methods:300strains of clinical isolated bacterial strains were classified according to the gram-positive bacteria and gram negative bacillus,and antibiotic drug susceptibility test was implemented in accordance with the unified plan.Results:Of the 300 strains of clinical isolated bacterial strains,152 strains were from sputum specimens(50.7%),56 strains from blood specimens(18.7%),52 srrains from urine specimens(17.3%)and 40 strains from human feces and wound secretions(13.3%).The research results of drug resistance rate of escherichia coli,acinetobacter baumannii and klebsiella showed that their worst drug resistance rate were ceftazidime(43.9%),imipenem(54.4%)and piperacillin(47.8%)respectively.Conclusion:The bacterial resistance takes on the rising trend,so the effective surveillance should be strenghened in high-risk population and high-risk wards.
出处 《华夏医学》 CAS 2015年第2期51-53,共3页 Acta Medicinae Sinica
关键词 外科 重症监护室 细菌分布 耐药性 surgical department intensive care unit (ICU) bacteria distribution drug resistance
  • 相关文献

参考文献4

二级参考文献33

  • 1张辉军,瞿介明,陈雪华,潘珏,朱迎钢,邵长周,周春妹.呼吸重症监护室痰标本分离的常见革兰阴性菌药物敏感性分析[J].中国临床医学,2007,14(3):313-315. 被引量:6
  • 2Beceiro A,Perez A,Fernandez-Cuenca F, et al. Genetic variability among ampC genes from acinetobacter genomic species[J]. Antimicrob Agents Chemother, 2009,53 (3):1177-1184.
  • 3Yang CH, Lee S, Su PW,et al. Genotype and antibiotic susceptibility patterns of drug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii isolates in Taiwan[J]. Microb Drug Resist,2008,14(4) :281-288.
  • 4Higgins PG,Wisplinghoff H,Stefanik D,et al. In vitro activities of β-1actamase inhibitors clavulanic acid, sulbactam, and tazobactam alone or in combination with/3-1actams against epidemiologically characterized multidrug-resistant Acinetobacter baumannii strains[J].Antimicrob Agents Chemother, 2004, 48(5) :1586-1592.
  • 5Wang M,Guo P,Sun HL. Molecular epidemiology of clinical isolates of carbapenem-resistant Acinetobacter spp from Chinese hospitals[J]. Antimicrob Agents Chemother, 2007, 51 (11) :4022-4028.
  • 6刘运德,楼永良.微生物学检验[M],2版.北京:人民卫生出版社,2005,8:196-197
  • 7Georges B, Conil JM, Dubouix A, et al. Risk of emergence of pseudo- monas aeruginosa resistance to beta - lactam antibiotics in intensive care units[J]. Crit Care Med, 2006,34(6) :1636 -1641.
  • 8Zadroga R, Williams DN, Gottschall R, et al. Comparison of 2 blood culture media shows significant differences in bacterial recovery for patients on antimicrobial therapy [ J ]. Clin Infect Dis, 2013,56 (6) :790-797.
  • 9Gaieski DF, Mikkelsen ME, Band RA, et al. Impact of time to anti- biotics on survival in patients with severe sepsis or septic shock in whon: early goal-directed therapy was initiated in the emergency department[J]. Crit Care Med,2008 ,38 :1045-1053.
  • 10Weinstein MP, Doern G:. A critical appraisal of the role of the clinical microbiology laboratory in the diagnosis of bloodstream in- fections[ J]. J Clin Microbio1.2011.49 : $26-29.

共引文献34

同被引文献3

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部